John E. Mullinax, MD, FACS
@JohnEMullinaxMD
Followers
880
Following
2K
Media
100
Statuses
927
Section Head, Surgical Oncology, Sarcoma Dept at Moffitt. APD of CGSO fellowship. Lab focused on Tcell-based #immunotherapy for #sarcoma. Tweets are my own.
Tampa, FL
Joined November 2015
Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025 Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors: • Cancer Biology •
0
6
7
Great panel session on Starting a Practice @SocSurgOnc Fellows Institute 2025 @acgme @AmCollSurgeons @AcademicSurgery @UnivSurg
0
9
24
Our latest published article @NatureComms | Multicellular #immuneecotypes within #solidtumors as predictors of benefits & #immuneresistance w #immunecheckpoint inhibitors | Great collaborative effort across #ORIEN Network @xuefwang Tingyi Li @MoffittNews
https://t.co/3DlJP9HGNQ
nature.com
Nature Communications - Cellular state cooccurrence signatures, such as carcinoma ecotypes may serve as potential biomarkers of response to cancer immunotherapy, however, their clinical utility...
0
3
7
@ctosociety @WTapMD @herbloong @saxotomy @JohnEMullinaxMD @CrisyRoland @emilykeungMD @RobinL_Jones @DAmbrosio_MD @sandrapdangelo @sandro_pasquali It was a great start of the morning. Thank you to the mentors and experts for joining and sharing their insights and expertise. Most importantly thank you for the young colleagues for attending, engaging and ask challenging and important questions.
1
8
14
Great opportunity for those who can not attend #CTOS2025 in person in Boca Raton or will be still on the way! You can join TARPSWG meeting online 👩💻
@TARPSWG Semiannual Meeting is going to start - join us 🖥️online on Nov 12th 8am-12pm EST https://t.co/8kfqMePnQ3
#CTOS2025 @ctosociety @SoMe4sarcoma #sarcoma
0
5
16
Crushed to hear this news over the weekend. Such a tremendous loss for our sarcoma community and the patients he served. Thinking of his family now and we will press on in our work, in remembrance of him.
Farewell to BVT 💔an honourary #Toronto Sarcoma member - our @ctosociety community lost a fierce patient champion, brilliant mind, quick wit and kind soul His memory is a blessing to all who knew him 🙏
0
1
11
Join Marine Potez, PhD at #SITC25 as she discusses the the feasibility and efficacy of TIL expansion from clear cell renal cell carcinoma to enhance TIL-based adoptive cell therapy. #MoffittSITC25 @sitcancer
0
2
10
Live from #SITC25: Daniel Abate-Daga, PhD, shares that CAR-TIL demonstrates potent tumor recognition and superior infiltration compared with traditional CAR-T cells. Key takeaways: • Murine TIL concentrate in tumors after adoptive transfer and gradually acquire EM phenotype.
0
8
12
Tomorrow at #SITC25: Daniel Abate-Daga, PhD shares that chimeric antigen receptor-engineered TIL (CAR-TIL) shows potent tumor recognition and greater tumor infiltration than conventional CAR-T cells. #MoffittSITC25 @sitcancer
0
4
11
I don’t care what anyone says, the world’s best airport is right here in my city. @CityofTampa @S_TAMPAChamber @TampaMagazines
1
0
5
🚨 Save the Date! 🚨 @TARPSWG meets at #CTOS2025! 📅 Nov 12 | 🕗 8 AM–12 PM (EST) 📍 The Boca Raton – ADDISON BALLROOM Updates on new studies, collaboration & innovation in sarcoma research. Let’s drive progress together! 💪 #ClinicalTrials #OncologyResearch #TARPSWG
0
9
19
Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025 Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors: • Cancer Biology •
0
2
7
#CTOS2025 is not only about great science, it's also a perfect opportunity for mentorship for trainees and young fellows! Don't miss the 🌅 Sunrise Mentorship Session on Nov 13, 7.00 am ( breakfast and coffee will be served ☕)! Check topics and mentors 🧑🏫on the graphic⬇️
2
18
35
Watch now: Alex Lazarides, MD (@alexlazarides), joins Cosi Belloso for an engaging discussion on orthopedic oncology and advances in osseointegration. https://t.co/4efFq1BpEN
0
3
8
We are looking for another #sarcoma medical oncologist!!!! Please reach out to me if you or some one you know is interested!!!!
2
11
34
Great presentation by Dr Poch from @MoffittNews GU Program about his innovative clinical trial with local delivery of TIL for bladder cancer patients. #cellcoast2025 @MoffittGUOnc
0
3
13
We are excited to kick off the second annual Cell Coast Conference, presented by Moffitt Cancer Center! Stay tuned as oncologists share the latest updates in cellular therapy. Follow along at #CellCoast25 for updates!
0
4
11
Don't miss out on the 2nd annual Cell Coast Conference, where leading experts, researchers and industry pioneers will converge to explore the latest breakthroughs in cellular cancer therapy. This premier event will feature cutting-edge discussions on emerging targets, advanced
2
6
16
Clinical trials are a patient’s best chance for a better outcome. Every trial represents hope for patients today and progress for patients tomorrow. Watch as I share why clinical trials are important for providing patients new options.👇 #ClinicalTrials #CancerResearch
0
4
23
An important question that needs to be answered. A true global effort amongst the sarcoma community.
Can patients with high-risk retroperitoneal #sarcoma benefit from neoadjuvant chemotherapy? The international EA7211/STRASS 2 #ClinicalTrial, led in the US by @kencardonaMD, aims to find out. More: https://t.co/vMkhLxk8Qy
#leiomyosarcoma #liposarcoma Cc: @EORTC @richardriedelmd
0
3
14